Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Malen

Showing results (1-10 of 40) with videos related to

Pageof 4
Sort By:
Comptes Rendus Hebdomadaires Des Seances De L'Academie Des Sciences. Serie D: Sciences Naturelles|October 18, 1971
[Pharmacological properties of a new gastric secretion inhibitor: (pyridyl-2)-2-thioacetamide (CMN 131)]X Pascaud, J C Poignant, C Malen
Arzneimittel-Forschung|November 1, 1975
Fenfluramine and 5-hydroxytryptamine. Part 2: Involvement of brain 5-hydroxytryptamine in the anorectic activity of fenfluramineJ Duhault, M Boulanger, C Voisin, et al.
Arzneimittel-Forschung|November 1, 1975
Fenfluramine and 5-hydroxytryptamine?. Part 1: Is fenfluramine or norfenfluramine involved in the decrease of brain 5-hydroxytryptamineJ Duhault, C Malen, M Boulanger, et al.
Clinical Neuropharmacology|January 1, 1988
Structure-activity relationships of tricyclic antidepressants, with special reference to tianeptineC Labrid, J Moleyre, J C Poignant, et al.
Cancer Causes & Control : CCC|March 23, 2024
Cannabis use after a cancer diagnosis in a population-based sample of cancer survivorsMimi Ton, Polly A Newcomb, Salene Jones, et al.
Journal of Empirical Research on Human Research Ethics : JERHRE|March 6, 2015
Awareness of Federal Regulatory Mechanisms Relevant to Community-Engaged Research: Survey of Health Disparities-Oriented NIH-Funded InvestigatorsStephanie M Fullerton, Emily E Anderson, Ketch Cowan, et al.
Fundamental & Clinical Pharmacology|January 1, 1993
The antagonist properties of S 11978 on 5HT3 receptors in N1E-115 neuroblastoma cellsP Morain, C Abraham, J M Lacoste, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|January 6, 2015
Design, development, and feasibility of a spanish-language cancer survivor support groupRachel M Ceballos, Yamile Molina, Rachel C Malen, et al.
Journal of the National Cancer Institute. Monographs|August 7, 2024
Item response theory analysis of benefits and harms of cannabis use in cancer survivorsSalene M W Jones, Mimi Ton, Rachel C Malen, et al.
British Journal of Cancer|July 7, 2021
Association between post-treatment circulating biomarkers of inflammation and survival among stage II-III colorectal cancer patientsXinwei Hua, Mario Kratz, Rachel C Malen, et al.
Pageof 4

Showing results (1-10 of 40) with videos related to

Sort By:
Pageof 4
Comptes Rendus Hebdomadaires Des Seances De L'Academie Des Sciences. Serie D: Sciences Naturelles|October 18, 1971
[Pharmacological properties of a new gastric secretion inhibitor: (pyridyl-2)-2-thioacetamide (CMN 131)]X Pascaud, J C Poignant, C Malen
Arzneimittel-Forschung|November 1, 1975
Fenfluramine and 5-hydroxytryptamine. Part 2: Involvement of brain 5-hydroxytryptamine in the anorectic activity of fenfluramineJ Duhault, M Boulanger, C Voisin, et al.
Arzneimittel-Forschung|November 1, 1975
Fenfluramine and 5-hydroxytryptamine?. Part 1: Is fenfluramine or norfenfluramine involved in the decrease of brain 5-hydroxytryptamineJ Duhault, C Malen, M Boulanger, et al.
Clinical Neuropharmacology|January 1, 1988
Structure-activity relationships of tricyclic antidepressants, with special reference to tianeptineC Labrid, J Moleyre, J C Poignant, et al.
Cancer Causes & Control : CCC|March 23, 2024
Cannabis use after a cancer diagnosis in a population-based sample of cancer survivorsMimi Ton, Polly A Newcomb, Salene Jones, et al.
Journal of Empirical Research on Human Research Ethics : JERHRE|March 6, 2015
Awareness of Federal Regulatory Mechanisms Relevant to Community-Engaged Research: Survey of Health Disparities-Oriented NIH-Funded InvestigatorsStephanie M Fullerton, Emily E Anderson, Ketch Cowan, et al.
Fundamental & Clinical Pharmacology|January 1, 1993
The antagonist properties of S 11978 on 5HT3 receptors in N1E-115 neuroblastoma cellsP Morain, C Abraham, J M Lacoste, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|January 6, 2015
Design, development, and feasibility of a spanish-language cancer survivor support groupRachel M Ceballos, Yamile Molina, Rachel C Malen, et al.
Journal of the National Cancer Institute. Monographs|August 7, 2024
Item response theory analysis of benefits and harms of cannabis use in cancer survivorsSalene M W Jones, Mimi Ton, Rachel C Malen, et al.
British Journal of Cancer|July 7, 2021
Association between post-treatment circulating biomarkers of inflammation and survival among stage II-III colorectal cancer patientsXinwei Hua, Mario Kratz, Rachel C Malen, et al.
Pageof 4